News
The new surgical technique incorporates a new surgical clamp that maintains eye pressure during the insertion of two tissue ...
A techno-economic analysis has found that French cultivated meat startup Gourmey's bioreactor system can reach production ...
Available for purchase in the U.S. Starting June 2025; Launching in Mexico Two Weeks Later NAPLES, FL / ACCESS Newswire / May 28, 2025 / Stemtech Corporation (OTCQB:STEK), the global leader in Human ...
The cultivated meat major Gourmey has cut the costs of producing cultivated meat to €7/kg at commercial scale.
The birth took place at Sher-e-Kashmir University of Agricultural Sciences and Technology (SKUAST-Kashmir). Officials say it ...
7h
Health and Me on MSNJapan Races To Develop World’s First Artificial Blood, Trials To BeginJapan is developing the world’s first artificial blood, aiming for clinical use by 2030 to tackle donor shortages and aging ...
Available for purchase in the U.S. Starting June 2025; Launching in Mexico Two Weeks Later NAPLES, FL / ACCESS Newswire / May 28, 2025 / Stemtech Corporation (OTCQB:STEK), the global leader in Human ...
The gene editing was performed using CRISPR-Cas9 technology and adhered to international biosafety protocols. Importantly, ...
21h
Zacks Small Cap Research on MSNNRXBF In Great Position for Exciting YearNRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...
A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...
13h
News-Medical.Net on MSNA collaborative initiative by ISSCR toward responsible adoption of stem cell modelsAdvances in human stem cell-derived disease models have the potential to augment our predictive power for the efficacy and ...
In a time of regulatory and scientific upheaval, stem cells are facing, and creating, new challenges, says regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results